Sarepta Therapeutics, Inc. Quarterly Current Ratio in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Sarepta Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2012 to Q2 2024.
  • Sarepta Therapeutics, Inc. Current Ratio for the quarter ending June 30, 2024 was 424 %, a 5.66% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 424 -25.4 -5.66% Jun 30, 2024
Q1 2024 451 +10.7 +2.43% Mar 31, 2024
Q4 2023 467 +8.78 +1.92% Dec 31, 2023
Q3 2023 473 -24.1 -4.85% Sep 30, 2023
Q2 2023 449 -86.7 -16.2% Jun 30, 2023
Q1 2023 440 -122 -21.7% Mar 31, 2023
Q4 2022 458 -119 -20.6% Dec 31, 2022
Q3 2022 498 -85.5 -14.7% Sep 30, 2022
Q2 2022 536 -53.9 -9.15% Jun 30, 2022
Q1 2022 562 -68.2 -10.8% Mar 31, 2022
Q4 2021 577 -97.1 -14.4% Dec 31, 2021
Q3 2021 583 -91.5 -13.6% Sep 30, 2021
Q2 2021 590 -96.5 -14.1% Jun 30, 2021
Q1 2021 630 -87.1 -12.1% Mar 31, 2021
Q4 2020 674 -86 -11.3% Dec 31, 2020
Q3 2020 674 -180 -21.1% Sep 30, 2020
Q2 2020 686 -256 -27.2% Jun 30, 2020
Q1 2020 717 -273 -27.6% Mar 31, 2020
Q4 2019 760 -231 -23.3% Dec 31, 2019
Q3 2019 854 -299 -25.9% Sep 30, 2019
Q2 2019 942 -276 -22.7% Jun 30, 2019
Q1 2019 990 -141 -12.5% Mar 31, 2019
Q4 2018 991 +51.9 +5.52% Dec 31, 2018
Q3 2018 1.15K +471 +68.9% Sep 30, 2018
Q2 2018 1.22K +629 +107% Jun 30, 2018
Q1 2018 1.13K +628 +125% Mar 31, 2018
Q4 2017 939 +512 +120% Dec 31, 2017
Q3 2017 683 +293 +75% Sep 30, 2017
Q2 2017 589 +292 +98.2% Jun 30, 2017
Q1 2017 503 +148 +41.6% Mar 31, 2017
Q4 2016 428 +9.76 +2.34% Dec 31, 2016
Q3 2016 390 -115 -22.8% Sep 30, 2016
Q2 2016 297 -377 -55.9% Jun 30, 2016
Q1 2016 355 -471 -57% Mar 31, 2016
Q4 2015 418 -428 -50.6% Dec 31, 2015
Q3 2015 506 -364 -41.9% Sep 30, 2015
Q2 2015 674 -48.9 -6.77% Jun 30, 2015
Q1 2015 826 +373 +82.5% Mar 31, 2015
Q4 2014 845 +524 +163% Dec 31, 2014
Q3 2014 870 +614 +240% Sep 30, 2014
Q2 2014 723 +546 +308% Jun 30, 2014
Q1 2014 453 +278 +159% Mar 31, 2014
Q4 2013 322 +152 +89.8% Dec 31, 2013
Q3 2013 256 +127 +98.6% Sep 30, 2013
Q2 2013 177 -1.01 -0.57% Jun 30, 2013
Q1 2013 175 -1.19 -0.68% Mar 31, 2013
Q4 2012 169 Dec 31, 2012
Q3 2012 129 Sep 30, 2012
Q2 2012 178 Jun 30, 2012
Q1 2012 176 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.